XYLB, or Xylulokinase, is an enzyme that plays a pivotal role in carbohydrate metabolism, specifically in the pentose phosphate pathway, which is essential for the generation of nucleotides and the reduction of nicotinamide adenine dinucleotide phosphate (NADPH). This enzyme catalyzes the phosphorylation of xylulose, a five-carbon sugar, to xylulose 5-phosphate, utilizing adenosine triphosphate (ATP) as a phosphate donor.
The activity of XYLB is crucial for cells to metabolize pentoses obtained from the diet or generated through the breakdown of nucleic acids. By converting xylulose into its phosphorylated form, XYLB facilitates the integration of these sugars into the pentose phosphate pathway, allowing for the production of ribose 5-phosphate, a building block for nucleotides, and NADPH, which is vital for biosynthetic reactions, antioxidative defense, and maintaining the cellular redox state.XYLB is encoded by a specific gene, and its expression can be regulated depending on the cell's metabolic needs. This regulation ensures that the pentose phosphate pathway is active when the demand for nucleotide synthesis or NADPH is high, such as during periods of rapid cell division or oxidative stress.Structurally, XYLB often possesses a conserved kinase domain that is responsible for its enzymatic activity. The binding of ATP and xylulose to this domain leads to the transfer of a phosphate group, a reaction that is typically magnesium-dependent for stabilization of the phosphoryl transfer.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Acetylates COX-2, leading to the production of 15R-HETE, which is converted to Resolvin D1, enhancing its biosynthesis. | ||||||
Sodium Salicylate | 54-21-7 | sc-3520 sc-3520A sc-3520B sc-3520C | 1 g 25 g 500 g 1 kg | $10.00 $26.00 $82.00 $139.00 | 8 | |
Inhibits NF-κB pathway, potentially increasing the expression of enzymes involved in Resolvin D1 biosynthesis. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
Inhibits sphingosine kinase, modulating sphingolipid rheostat, which may augment Resolvin D1 activity. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Activates PPARγ, which may enhance Resolvin D1 synthesis by increasing the expression of related enzymes. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Activates PPARα, potentially increasing the expression of enzymes involved in the biosynthesis of Resolvin D1. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
May upregulate biosynthetic enzymes for Resolvin D1 through anti-inflammatory actions. | ||||||
Palmitoylethanolamide | 544-31-0 | sc-202754 sc-202754A sc-202754B sc-202754C sc-202754D | 10 mg 50 mg 500 mg 1 g 10 g | $80.00 $243.00 $2091.00 $3339.00 $16657.00 | ||
Enhances the activity of Resolvin D1 by acting on PPARα, which may increase biosynthesis of resolvins. | ||||||
Montelukast Sodium | 151767-02-1 | sc-202231 sc-202231A sc-202231B | 10 mg 25 mg 250 mg | $51.00 $85.00 $161.00 | 5 | |
CysLTR1 antagonist that may enhance Resolvin D1 function by reducing leukotriene-mediated pro-inflammatory signaling. | ||||||
Polydatin | 65914-17-2 | sc-203203 | 10 mg | $94.00 | 5 | |
May stimulate the biosynthesis of Resolvin D1 through activation of AMPK and Nrf2 pathways. | ||||||